BRCA-Related Breast and/or Ovarian Cancer syndrome is a hereditary cancer syndrome caused by pathogenic variants in the BRCA1 and BRCA2 genes. It results in increased risk for breast, ovarian, prostate, and pancreatic cancers and possibly melanoma. Experts believe...
In 2022, many new therapies and tests for cancer were approved, but a significant number of patients are still not receiving appropriate therapies. Suboptimal testing paradigms, reimbursement issues and physicians’ inability to keep up with rapidly advancing...
Myriad Genetics is set to share information about guarded BRCA variants in a public database, marking a significant shift in the company’s approach to sharing genetic information. Previously, the company had been criticized for guarding such information and...